アジェンダ
8:00 AM — 8:30 AM
8:30 AM — 8:45 AM
8:45 AM — 10:30 AM
SESSION 1: INTRODUCTION TO BENEFIT-RISK MANAGEMENT10:30 AM — 11:00 AM
11:00 AM — 11:45 AM
SESSION 2: INTRODUCTION TO BENEFIT-RISK METHODOLOGIES11:45 AM — 12:15 PM
SESSION 3: EXAMPLES OF APPLICATION OF BENEFIT-RISK METHODOLOGIES12:15 PM — 1:15 PM
1:15 PM — 1:45 PM
SESSION 4: DESIGNING RISK MANAGEMENT SYSTEMS1:45 PM — 2:00 PM
SESSION 5: DOS AND DON’TS IN SAFETY SPECIFICATION2:00 PM — 2:45 PM
SESSION 6: TOOLBOX FOR PHARMACOVIGILANCE PLANNING2:45 PM — 3:15 PM
3:15 PM — 4:00 PM
SESSION 7: EFFICACY SPECIFICATION AND FOLLOW-UP PLAN4:00 PM — 5:00 PM
SESSION 8: OPTIONS FOR RISK MINIMISATION5:00 PM — 6:00 PM
8:20 AM — 9:45 AM
SESSION 9: EVALUATION OF RISK MINIMISATION EFFECTIVENESS9:45 AM — 10:15 AM
10:15 AM — 12:15 PM
SESSION 10: BENEFIT-RISK MANAGEMENT PLAN – CASE STUDIES12:15 PM — 1:15 PM
1:15 PM — 2:15 PM
SESSION 11: BENEFIT OPTIMISATION